CIK: 0001594912
Total reported value
$29.2M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | AIMT | Aimmune Therapeutics INC | Stock-Other | 40.96% | — | -18.85% | |
| 2 | AERIEUR | Aerie Pharmaceuticals INC | Stock-Other | 34.92% | — | — | |
| 3 | EPZMEUR | Epizyme INC | Stock-Other | 6.83% | — | +0.97% | |
| 4 | INSM | Insmed INC | Stock-Healthcare | 5.65% | — | +72.88% | |
| 5 | ALDR1EUR | Alder Biopharmaceuticals INC | Stock-Other | 4.18% | — | — | |
| 6 | XLRN | Acceleron Pharma INC | Stock-Other | 3.63% | — | — | |
| 7 | DNLI | Denali Therapeutics INC | Stock-Other | 1.37% | — | — | |
| 8 | ✓ | Juno Therapeutics | Stock-Other | 1.36% | — | -5.56% | |
| 9 | QURE | uniQure N.V. | Stock-Other | 0.75% | — | — | |
| 10 | ✓ | Loxo Oncology INC | Stock-Other | 0.35% | — | -16.78% | |
| 11 | ✓ | Alder Biopharmaceuticals INC | Stock-Other | 0.01% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | AIMT | Aimmune Therapeutics INC | +2.6% | -18.85% | Trim |
| 2 | AERIEUR | Aerie Pharmaceuticals INC | +2% | — | Unchanged |
| 3 | INSM | Insmed INC | +1.9% | +72.88% | Add |
| 4 | XLRN | Acceleron Pharma INC | -0.1% | — | Unchanged |
| 5 | ✓ | Loxo Oncology INC | -0.2% | -16.78% | Trim |
| 6 | ✓ | Juno Therapeutics | -0.3% | -5.56% | Trim |
| 7 | ALDR1EUR | Alder Biopharmaceuticals INC | -1% | — | Unchanged |
| 8 | EPZMEUR | Epizyme INC | -5.1% | +0.97% | Add |
| 9 | DNLI | Denali Therapeutics INC | — | NEW | New buy |
| 10 | QURE | uniQure N.V. | — | NEW | New buy |
| 11 | JNCEEUR | Jounce Therapeutics INC | — | EXIT | Sold out |
| 12 | DERMEUR | Dermira INC | — | EXIT | Sold out |
| 13 | ✓ | Orexigen Therapeutics INC Com New | — | EXIT | Sold out |
| 14 | ZFGNUSD | Zafgen INC | — | EXIT | Sold out |
| 15 | ✓ | Alder Biopharmaceuticals INC | — | NEW | New buy |